BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-02-22

Reporting Person: GREY MICHAEL G (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-22	Common Stock	M	7500	$38.59	Acquired	33750	Direct
2016-02-22	Common Stock	S	7500	$80.00	Disposed	26250	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-22	Stock Option (right to buy) Common Stock	$38.59	M	7500	Disposed	2018-05-21	Common Stock (7500)	Direct

F1: Trade made pursuant to a 10b5-1 plan executed on August 14, 2015.

F2: All shares were sold at exactly $80.00.

F3: Original option grant vests 6/48ths on November 22, 2008, and 1/48th on the 22nd day of every month thereafter.

F4: Reflects the number of stock options that remain from this specific stock option grant following the reported transaction.